曹強(qiáng)，男，住院醫(yī)師，醫(yī)學(xué)碩士，能夠熟練處理泌尿外科常見疾病的診斷及治療。專業(yè)研究方向?yàn)槟I癌的基礎(chǔ)和臨床研究，在本專業(yè)領(lǐng)域發(fā)表學(xué)術(shù)論文十余篇。目前參與自然科學(xué)基金項(xiàng)目兩項(xiàng)?！究蒲许?xiàng)目】1. 自然科學(xué)基金項(xiàng)目：mTOR 信號(hào)通路基因遺傳變異與腎癌發(fā)病和耐藥機(jī)制的研究主要參與者。2. 青年科學(xué)基金項(xiàng)目：MicroRNA-34b/c 基因啟動(dòng)子區(qū)多態(tài)性及其甲基化與腎癌遺傳易感性及其機(jī)制研究主要參與者?！敬砦恼隆?. Cao Q, Qin C, Ju X, Meng X, Wang M, Zhu J, Li P, Chen J, Zhang Z, Yin C. Chromosome 11q13.3 variant modifies renal cell cancer risk in a Chinese population. Mutagenesis, 2012 May; 27(3):345-50. 2. Cao Q, Ju X, Li P, Meng X, Shao P, Cai H, Wang M, Zhang Z, Qin C, Yin C. A functional variant in the MTOR promoter modulates its expression and is associated with renal cell cancer risk. PLoS One, 2012; 7(11):e50302.3. Cao Q, Qin C, Meng X, Ju X, Ding Q, Wang M, Zhu J, Wang W, Li P, Chen J, Zhang Z, Yin C. Genetic polymorphisms in APE1 are associated with renal cell carcinoma risk in a Chinese population. Mol Carcinog, 2011 Nov; 50(11):863-70.4. Cao Q, Qian M, Wang XF, Wang B, Wu HW, Zhu XJ, Wang YW, Guo J. Negative feedback regulation of Raf/MEK/ERK cascade after sublethal cerebral ischemia in the rat hippocampus. Neurochem Res, 2011 Jan; 36(1):153-62. 5. Qin C, Cao Q, Ju X, Wang M, Meng X, Zhu J, Yan F, Li P, Ding Q, Chen J, Gu M, Zhang W, Yin C, Zhang Z. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma. Ann Oncol. 2012 Apr; 23(4):981-9.6. Qin C, Cao Q, Li P, Ju X, Wang M, Chen J, Wu Y, Meng X, Zhu J, Zhang Z, Lu Q, Yin C. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population. PLoS One, 2012; 7(1):e28829.7. Chen J, Cao Q, Qin C, Shao P, Wu Y, Wang M, Zhang Z, Yin C. GPx-1 polymorphism (rs1050450) contributes to tumor susceptibility: evidence from meta-ysis. J Cancer Res Clin Oncol, 2011 Oct; 137(10):1553-61.8. Zhang L, Mi Y, Cao Q, Wang W, Qin C, Wei J, Zhou Y, Li Y, Tang M, Liu W, Zhang W, Zou J. Update ysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk. Mol Biol Rep, 2012 Apr; 39(4):3435-41.9. Chen J, Shao P, Cao Q, Li P, Li J, Cai H, Zhu J, Wang M, Zhang Z, Qin C, Yin C. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population. PLoS One, 2012; 7(7):e40817.10. Li P, Cao Q, Shao PF, Cai HZ, Zhou H, Chen JW, Qin C, Zhang ZD, Ju XB, Yin CJ. Genetic polymorphisms in HIF1A are associated with prostate cancer risk in a Chinese population. Asian J Androl, 2012 Nov; 14(6):864-9.11. Wang S, Cao Q, Wang X, Li B, Tang M, Yuan W, Fang J, Qian J, Qin C, Zhang W. P-1 4G/5G Polymorphism Contributes to Cancer Susceptibility: Evidence from Meta-Analysis. PLoS One. 2013;8(2):e56797.